Single-Port Vitrectomy and “Oleodelamination” for the Management of Retinal Detachment Complicated by Proliferative Vitreoretinopathy
Edward H. Wood, MD  |  December 8, 2019
Continue Reading
Cost Analysis of Pneumatic Retinopexy versus Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment
Daniel Su, MD  |  December 2, 2019
Continue Reading
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
Rehan M. Hussain, MD  |  November 22, 2019
Continue Reading
A Human Amniotic Membrane Plug to Promote Retinal Break Repair and Recurrent Macular Hole Closure
Mohsin H. Ali, MD  |  November 6, 2019
Continue Reading
Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2
Akshay S. Thomas, MD  |  October 29, 2019
Continue Reading
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs. Aflibercept vs. Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Clinical Trial by the LEAVO Study Group
Avni P. Finn, MD  |  October 17, 2019
Continue Reading
Rhegmatogenous Retinal Detachment in Children: Clinical Factors Predictive of Successful Surgical Repair
Vlad Matei, MD  |  October 11, 2019
Continue Reading
Phenotypic Spectrum of Pentosan Polysulfate Sodium–Associated Maculopathy: A Multicenter Study
Joshua D. Levinson, MD  |  October 1, 2019
Continue Reading
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Christopher Aderman, MD  |  September 11, 2019
Continue Reading
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration
Brian K. Do, MD  |  September 6, 2019
Continue Reading
The Port Delivery System with Ranibizumab for nAMD: Results from the Phase 2 LADDER Study
Joshua D. Levinson, MD  |  September 4, 2019
Continue Reading
FLUID Study 24-Month Results: Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen
Christopher Aderman, MD  |  August 28, 2019
Continue Reading